Moderna Inc (LTS:0A45)
$ 39.3575 -1.0175 (-2.51%) Market Cap: 15.50 Bil Enterprise Value: 9.98 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 58/100

Moderna Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 12, 2020 / 06:20PM GMT
Geoffrey Christopher Meacham
BofA Merrill Lynch, Research Division - Research Analyst

Okay. Good afternoon, everyone. Welcome to the afternoon sessions of the first day of the BofA Virtual Vegas Conference. My name is Geoff Meacham, I'm the senior biopharma analyst at BofA here, and I have Alec Stranahan from my team as well. And we're thrilled to have Moderna present this afternoon.

And speaking on behalf of Moderna, we have Stéphane Bancel, who is CEO. We also have Lorence Kim who's CFO. Guys, are you there?

Lorence H. Kim
Moderna, Inc. - CFO & Treasurer

Yes.

StÃ;phane Bancel
Moderna, Inc. - CEO & Director

© -

Thank you for having us.

Questions & Answers

Geoffrey Christopher Meacham
BofA Merrill Lynch, Research Division - Research Analyst

Okay. Perfect. Let's get right into it. So Stéphane, obviously, you've had a lot of success and a lot of visibility with respect to the COVID vaccine. I want to get a sense from you. What

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot